Food and Drug Administration
February 16, 2005
Slides
Influenza Virus Vaccine Composition 2005-2006, Dr. Roland Levandowski, MD, FDA (HTM) (PPT)
U.S. Influenza Surveillance 2004-2005, Keiji Fukuda, National Center for Infectious Diseases (PDF) (PPT)
Human H5N1 ases, 2004-2005, Dr. Nancy Cox, PhD, National Center for Infectious Diseases (HTM) (PPT)
DoD Global Influenza Surveillance 2004-2005, Linda Canas, Brooks City-Base, TX (HTM) (PPT)
Influenza Vaccine Responses, Dr. Roland Levandowski, MD, FDA (HTM) (PPT)
Status of Candidate Vaccine Strains and Potency Reagents, Dr. Zhiping Ye, MD, PhD, FDA (HTM) (PPT)
Influenza Vaccine Manufacturing - Industry Perspective, Albert Thomas (HTM) (PPT)
Options for Inflluenza Vaccine Composition 2005-2006, Dr. Roland Levandowski, MD, FDA (HTM) (PPT)